CH296566A - Process for the preparation of a 17-methylpregnene compound. - Google Patents

Process for the preparation of a 17-methylpregnene compound.

Info

Publication number
CH296566A
CH296566A CH296566DA CH296566A CH 296566 A CH296566 A CH 296566A CH 296566D A CH296566D A CH 296566DA CH 296566 A CH296566 A CH 296566A
Authority
CH
Switzerland
Prior art keywords
methyl
compound
methylpregnene
etio
preparation
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellschaft Ciba
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of CH296566A publication Critical patent/CH296566A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Description

  

      Verfahren        zur    Herstellung einer     17-Methylpregnenverbindung.       Es wurde gefunden, dass man zu einer  neuen     17-Methylpregnenverbindung    gelangen  kann, wenn man ein     44-3-Oxo-17a-methyl-          ätio-chlolensäurehalogenid    mit einer     Methyl-          Metallverbindimg    reagieren lässt.  



  Das neue Verfahrensprodukt, das     .d        4-17a-          Methyl-3,20-dioxo-pregnen        (17a-Methylprog-          esteron)    vom F. = 129 bis 130  ist     progesta-          tiv    hochwirksam. Es soll als Heilmittel oder  als     Zwiselienprodukt    zur Herstellung von  Heilmitteln Verwendung finden.  



  Bei der verfahrensgemässen     Unisetzung     verwendet man als     Methvl-lIetallverbind-Lui-          gen    zum Beispiel eine solche des Magnesiums,  Kadmiums oder Zinks.  



       Beispiel.:     1. Gewichtsteil d     4-17a-Methyl-3-oxo-ätio-          cholensäurechlorid,    gelöst. in 30     Voluinteilen          Xther,    wird tropfenweise mit einer Lösung  von     Dimethylcadmium    (bereitet in üblicher  Weise aus 7,6 Gewichtsteilen     Magnesiumspä-          nen,    30     Volumteilen    Äther, 10 Gewichtsteilen       Methylbromid    und 9 Gewichtsteilen     Cad-          miumehlorid)    in Äther versetzt.

   Das     Reak-          tionsgemisch    wird anschliessend zwei Stunden  unter Rühren zum Sieden erhitzt, dann vor  sichtig mit Wasser zersetzt     und    schliesslich  mit Äther extrahiert. Die übliche Aufarbei  tung des ätherischen     Auszuges    liefert 0,9 Ge  wichtsteile rohes     17a-Methyl-progesteron    der  Formel  
EMI0001.0037     
    welches nach dein     1Jmkristallisieren    aus Äther  Petroläther bei 129 bis 130  schmilzt; [a] D  _     -I-    113  (in Chloroform).  



  Das als Ausgangsmaterial verwendete  d     4-17a-Methyl-3-oxo-ätio    -     cholensäure-        chlorid     kann aus der bekannten d     5-17a-Methyl-3-ss-          oxy-ätio-ehlolensäure    auf folgendem Wege be  reitet werden:

    Die     Oxy-säure    wird in     Eisessig-Lösung     unter Zusatz von     Natriumaeetat    mit 1     Mol     Brom behandelt, das erhaltene rohe     5,6-Di          bromid    mit     Chrointrioxy    d in     Eisessig-Lösung     oxydiert, und schliesslich wird ohne     Isolierung     von     Zwischenstufen    eine     Entbromung    mit  Zinkstaub in Eisessig vorgenommen.

   Aus 1 Ge  wichtsteil     J5-17a-Metliyl-3ss-oxy-ätio-eholen-          säure    erhält man nach dem     L:mkristallisieren     des Rohproduktes aus Aceton 0,8 Gewichts  teile d     4-17a-Methyl-3-oxo-ätio-cholensäure,    die  bei 291 bis 293  schmilzt:

   [a] D =     -I-89     (in       Dioxan).    Zur Bereitung des     Säureclflorids     wird die d     4-17a-Methyl-3-oxo-ätio-eholensä-LLive     in Äthanol     aufgenommen,    mit einem.

   Äqui  valent     0,1n-Natronlauge    versetzt, die Lösung      zur Trockne eingedampft und schliesslich das  erhaltene     Natriumsalz    im Hochvakuum bei  120      getroeknet.    Das     Natriumsalz    wird an  schliessend in absolutem Benzol     aufgeschlemmt     und nach Zusatz von wenig     Pyridin    mit       Oxaly        lchlorid    versetzt. Die Reaktion ist nach  30     :Minuten    beendet, worauf die Lösung zur  Trockne eingedampft wird.

   Das rohe     Säure-          ehlorid    wird in Äther aufgenommen, die Lö  sung vom ausgeschiedenen N     atriumehlorid    ab  filtriert und direkt in der oben beschriebenen  Weise mit     Dimethylcadmium    umgesetzt.



      Process for the preparation of a 17-methylpregnene compound. It has been found that a new 17-methylpregnene compound can be obtained if a 44-3-oxo-17a-methyl-etio-chlolenic acid halide is allowed to react with a methyl metal compound.



  The new process product, the .d 4-17a-methyl-3,20-dioxo-pregnen (17a-methylprogesterone) from F. = 129 to 130, is highly progestationally effective. It should be used as a remedy or as an intermediate product for the production of medicinal products.



  In the process according to the method, the metal-to-metal compounds used are, for example, magnesium, cadmium or zinc.



       Example: 1st part by weight of d 4-17a-methyl-3-oxo-etio- cholenic acid chloride, dissolved. in 30 parts by volume of Xther, a solution of dimethylcadmium (prepared in the usual way from 7.6 parts by weight of magnesium shavings, 30 parts by volume of ether, 10 parts by weight of methyl bromide and 9 parts by weight of cadmium chloride) in ether is added dropwise.

   The reaction mixture is then heated to boiling for two hours while stirring, then carefully decomposed with water and finally extracted with ether. The usual processing of the essential extract provides 0.9 parts by weight of raw 17a-methyl-progesterone of the formula
EMI0001.0037
    which, after crystallizing from ether, melts petroleum ether at 129 to 130; [a] D-I-113 (in chloroform).



  The d 4-17a-methyl-3-oxo-etio-cholenic acid chloride used as the starting material can be prepared from the known d 5-17a-methyl-3-ss-oxy-etio-ehlolenic acid in the following way:

    The oxy acid is treated in glacial acetic acid solution with the addition of sodium acetate with 1 mol of bromine, the crude 5,6-di bromide obtained is oxidized with chrointrioxy d in glacial acetic acid solution, and finally, without isolation of intermediate stages, debromination with zinc dust in glacial acetic acid performed.

   From 1 part by weight of J5-17a-methyl-3ss-oxy-etio-eholenic acid, after crystallizing the crude product from acetone, 0.8 parts by weight of 4-17a-methyl-3-oxo-etio-cholenic acid are obtained, which melts at 291 to 293:

   [a] D = -I-89 (in dioxane). To prepare the acid chloride, the d 4-17a-methyl-3-oxo-etio-eholensä-LLive is taken up in ethanol with a.

   Equi valent 0.1N sodium hydroxide solution is added, the solution is evaporated to dryness and the sodium salt obtained is finally dried in a high vacuum at 120 °. The sodium salt is then suspended in absolute benzene and, after adding a little pyridine, oxalyl chloride is added. The reaction is over after 30 minutes, after which the solution is evaporated to dryness.

   The crude acid chloride is taken up in ether, the solution of the precipitated sodium chloride is filtered off and reacted directly with dimethylcadmium in the manner described above.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung einer 17-Me- thyl-pregnenverbindung, dadurch gekenn- zeichnet, dass man ein A 4-3-Ozo-17a-methyl- ätio-cholensäureha.logenid mit einer llethyl- lletallverbindung reagieren lässt. Das neue Verfahrensprodukt, das d -1-17a- hlethyl-3,20-dioxo-pregnen (17a-Methyl-prog- esteron) vom F. = 129 bis 130 ist progestativ hochwirksam. PATENT CLAIM: A process for the production of a 17-methyl-pregnene compound, characterized in that an A 4-3-Ozo-17a-methyl-etio-cholenic acid allogenidic reacts with a methyl-ethyl-metal compound. The new product of the process, d -1-17a-ethyl-3,20-dioxo-pregnen (17a-methyl-progesterone) from F. = 129 to 130, is highly progestationally effective. Es soll als Heilmittel oder als Zwischenprodukt zur Herstellung von Heil mitteln Verwendung finden. UNTERANSPRUCH: Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man als hlethyl-Metall- verbindung Dimethyl-eadmium verwendet. It is said to be used as a remedy or as an intermediate for the production of medicinal products. SUBCLAIM: Process according to patent claim, characterized in that dimethyl-eadmium is used as the methyl-metal compound.
CH296566D 1949-01-31 1949-01-31 Process for the preparation of a 17-methylpregnene compound. CH296566A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH296566T 1949-01-31
CH284942T 1949-01-31

Publications (1)

Publication Number Publication Date
CH296566A true CH296566A (en) 1954-02-15

Family

ID=25732465

Family Applications (1)

Application Number Title Priority Date Filing Date
CH296566D CH296566A (en) 1949-01-31 1949-01-31 Process for the preparation of a 17-methylpregnene compound.

Country Status (1)

Country Link
CH (1) CH296566A (en)

Similar Documents

Publication Publication Date Title
DE2810253A1 (en) NEW CHALCONDERIVATES AND THE PROCESS FOR THEIR PRODUCTION
CH494219A (en) 17alpha-3-hydroxypropyl-4-androstene-3beta 17beta-diol
CH296566A (en) Process for the preparation of a 17-methylpregnene compound.
AT202152B (en) Process for the preparation of new dimethylaminopropylidene thiaxanthenes.
AT323154B (en) PROCESS FOR THE PRODUCTION OF NEW 5-METHOXY-2-METHYLINDOL-3-ACETIC ACID DERIVATIVES AND OF THEIR SALTS
DE1286045B (en) Process for the preparation of N-substituted 3-methoxy-6-oxo-14-hydroxy-morphinan derivatives
AT206899B (en) Process for the preparation of new, substituted 3,5-dioxo-tetrahydro-1,2,6-thiadiazine-1,1-dioxyden
DE897406C (en) Process for the preparation of pyrazolone compounds
AT252912B (en) Process for the preparation of 3-methylflavone-8-carboxylic acid and its esters
AT248622B (en) Process for the production of new 2-cyano-3-oxo-steroids
DE862601C (en) Process for the production of new diphenyl- (A2,3-2-methyl-propenyl) -acetic acid dialkylamino-alkyl esters and their salts
DE1468878C (en) Process for the preparation of 11 beta, 17 beta-dihydroxy-17 alpha-methyl-delta to the power of 2 -5 alpha-androstene
CH509992A (en) Process for the preparation of sulfonamides
AT253704B (en) Process for the preparation of the new 7α-methyl-16α-hydroxy-estrone and its 3,16-diacetate
AT229318B (en) Process for the preparation of the new 3-methoxy-2-sulfanilamido-pyrazine
DE1595911C (en) IH 2,3 Benzoxazin 4 (3H) one and processes for their production
DE1518020C (en) 4 (4 chlorophenoxy) 3 hydroxy 4 methylvaleric acid, their lower alkyl esters and physiologically acceptable salts, processes for their manufacture and drugs containing these compounds
AT242139B (en) Process for the preparation of new piperidine derivatives
AT240540B (en) Process for the preparation of 4-chloro-Δ <4> -3-ketosteroid compounds
CH263037A (en) Process for the preparation of a new derivative of 2-oxy-5-aminobenzoic acid.
CH395998A (en) Process for the preparation of α-pyrrolidino-valerophenones
CH298333A (en) Process for the preparation of a 17-methylpregnene compound.
CH349599A (en) Process for the production of new antituberculotics
CH579012A5 (en) Tetrahydroxy-tetrahalo-diphenyl ethers and esters prodn - by halogenating 2,4,2',4' tetrahydroxydiphenyl (deriv) used for polymer stabilisers
CH569707A5 (en) Indenylacetic acid derivs - useful as antiinflammatory agents